Lifecore Biomedical sale to affiliates of Webster Equity Partners

Webster Equity Partners to Acquire Lifecore Biomedical

September 28, 2026

Pharmaceuticals

Webster Equity Partners entered into a definitive agreement to acquire Lifecore Biomedical in a take-private transaction valued at up to $663.7 million, including contingent value rights tied to performance milestones. Lifecore common shareholders are to receive $6.28 per share in cash at closing, plus a CVR; the transaction is expected to close in the fourth quarter of 2026, subject to approvals and other closing conditions.

Repligen Acquires BioLife Solutions for $1.5 Billion

July 23, 2026

Healthcare Services

Repligen has entered into a definitive agreement to acquire BioLife Solutions in a cash-and-stock transaction with an enterprise value of approximately $1.5 billion. The deal is expected to close in the fourth quarter of 2026, subject to BioLife shareholder approval and regulatory clearances.

Equitable Holdings and Corebridge Financial Merge in ~$22B All-Stock Deal

March 25, 2026

Financial Services

Equitable Holdings and Corebridge Financial entered into a definitive all-stock merger valued at approximately $22 billion, creating a scaled retirement, life, wealth and asset management company with more than 12 million customers. The combined company will operate under the Equitable name and is expected to close by year-end 2026 (subject to regulatory approvals and customary closing conditions).

Merit Medical Systems Acquires Biolife Delaware

May 28, 2025

Medical Devices

Merit Medical Systems has acquired Biolife Delaware, a Sarasota, Florida-based maker of StatSeal and WoundSeal hemostatic devices, in a cash transaction valued at approximately $120 million (including assumed liabilities). The deal expands Merit's hemostasis and wound-care product portfolio and is expected to modestly impact 2025 non-GAAP profitability while enhancing Merit's ability to serve a broad set of percutaneous procedure end markets.

EQT Acquires LSP (Life Sciences Partners)

November 10, 2021

Financial Services

EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.

WELL Health Acquires CRH Medical Corporation

February 8, 2021

Healthcare Services

WELL Health Technologies announced an agreement to acquire all outstanding shares of CRH Medical Corporation for approximately US$292.7M in equity (US$4.00 per share) plus assumed debt, funded by a C$295.5M equity private placement led by Mr. Li Ka-shing and committed credit facilities. The acquisition gives WELL immediate scale in the U.S. healthcare market via CRH's anesthesia services across 69 ASCs and GI clinics, a network of ~3,200 gastroenterologists, and a patented medical device (the CRH O'Regan System), while materially improving WELL's revenue and cash-flow profile.